High efficacy of direct‐acting anti‐viral agents in hepatitis C virus‐infected cirrhotic patients with successfully treated hepatocellular carcinoma - Concepedia

Concepedia

Publication | Open Access

High efficacy of direct‐acting anti‐viral agents in hepatitis C virus‐infected cirrhotic patients with successfully treated hepatocellular carcinoma

DOI Full Paper Access

32

Citations

24

References

2018

Year

Marcello Persico, Andrea Aglitti, Alessio Aghemo, Maria Rendina, Ana Lleò, Alessia Ciancio, V. Di Marco, Pietro Lampertico, Maurizia Rossana Brunetto, Massimo Zuin,

Alimentary Pharmacology & Therapeutics

Abstract

This large real-life study proves that the efficacy of DAA in cirrhotic patients is not impaired by successfully treated HCC.

References

	Year	Citations
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection Michael Fried, Mitchell L. Shiffman, K. Rajender Reddy, New England Journal of Medicine	2002	6.4K
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma Journal of Hepatology HepatologyMedicineHistopathologyLiver CancerOncology	2012	5.2K
Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection Nezam H. Afdhal, Stefan Zeuzem, Paul Y. Kwo, New England Journal of Medicine	2014	1.7K
EASL Recommendations on Treatment of Hepatitis C 2015 Journal of Hepatology HepatologyHepatitis CViral HepatitisAntiviral TherapyHepatitis	2015	1.2K
Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy María Reig, Zoe Mariñó, Christie Perelló, Journal of Hepatology HepatologyHepatitis CHcv-related HccViral HepatitisHigh Rate	2016	1K
ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis Fred Poordad, Christophe Hézode, Roger Trinh, New England Journal of Medicine	2014	872
HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma George N. Ioannou, Pamela K. Green, Kristin Berry Journal of Hepatology Hcv EradicationHepatologyHepatitis CViral HepatitisImmunology	2017	568
A Sustained Virologic Response Reduces Risk of All-Cause Mortality in Patients With Hepatitis C Lisa I. Backus, Derek Boothroyd, Barbara Phillips, Clinical Gastroenterology and Hepatology All-cause MortalityHepatologyHepatitis CViral HepatitisAntiviral Therapy	2011	491
Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post‐liver transplantation recurrence Fred Poordad, Eugene R. Schiff, John M. Vierling, Hepatology	2016	456
Sofosbuvir and Ribavirin Prevent Recurrence of HCV Infection After Liver Transplantation: An Open-Label Study Michael P. Curry, Xavier Forns, Raymond T. Chung, Gastroenterology	2014	330

Page 1